6th Annual Gene Therapy for Rare Disorders Europe
Evvnt Promotion / evvnt
Archiv
25.10.2022 - 27.10.2022 London Marriott Hotel Regents Park, 128 King Henry's Road, NW3 3ST London, Großbritannien
Time: 8:00 am to 5:00 pm
Kongressthemen
As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever.
As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Eva Andres-Mateos, Senior Director of Translational Research, Atsena Therapeutics, Inês Alves, Patient Expert and Member of the Committee for Orphan Medicinal Products, EMA, Stuart Beattie, Gene Therapy Global Regulatory CMC, Biogen
Speakers: Eva Andres-Mateos, Senior Director of Translational Research, Atsena Therapeutics, Inês Alves, Patient Expert and Member of the Committee for Orphan Medicinal Products, EMA, Stuart Beattie, Gene Therapy Global Regulatory CMC, Biogen
Anfragen und Anmeldung:
https://go.evvnt.com/1234024-2?pid=4832
Frau Emily Birt
Klinische Forschung, Public Health
Sprache
Englisch
Englisch
Kongressgebühr
GBP 2099.00 - GBP 4496.00
GBP 2099.00 - GBP 4496.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
